Interim Report January – September 2019
BioArctic: Strong continued progress year to date Summary of key events for the third quarter 2019 ·BioArctic and Eisai presented new data regarding BAN2401 at the Alzheimer’s Association International Conference® (AAIC®) in July that confirmed BAN2401’s unique characteristics and was consistent with previously presented results Key events after the period ·There are no key events to report after the period Financial summary for the period January – September 2019 · Net revenues for the period increased by MSEK 56.7 to MSEK 255.4 (198.6), primarily attributable